CLOROX CO /DE/
CLXAPI behind this page
CLX Q3 2026 request
Playground key active
/api/financials?ticker=CLX&year=2026&quarter=3
Pick an endpoint and run the request.
Income Statement
| Metric | Q3 2026 | Q3 2025 | YoY |
|---|---|---|---|
| Revenue | 1,670 | 1,668 | +0.1% |
Show Business Segments breakouts |
|||
| Health and Wellness · Operating Segments | 629 | 630 | -0.2% |
| Household · Operating Segments | 482 | 469 | +2.8% |
| International · Operating Segments | 285 | 263 | +8.4% |
| Lifestyle · Operating Segments | 277 | 306 | -9.5% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -3 | — | — |
| Operating Segments | 1,673 | 1,668 | +0.3% |
| Cost of Revenue | 948 | 924 | +2.6% |
Show Business Segments breakouts |
|||
| Health and Wellness · Operating Segments | 319 | 305 | +4.6% |
| Household · Operating Segments | 316 | 308 | +2.6% |
| International · Operating Segments | 177 | 162 | +9.3% |
| Lifestyle · Operating Segments | 146 | 154 | -5.2% |
| Gross Profit | 722 | 744 | -3.0% |
| Selling, General & Administrative | 229 | 267 | -14.2% |
| Advertising Expense | 177 | 207 | -14.5% |
| Research & Development | 27 | 27 | 0.0% |
| Interest Expense | 27 | 23 | +17.4% |
| Other Expense Income Net | 6 | -34 | +117.6% |
| Income Before Taxes | 256 | 254 | +0.8% |
| Income Tax Expense (Benefit) | 65 | 63 | +3.2% |
| Net Income | 191 | 191 | 0.0% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 4 | 5 | -20.0% |
| Retained Earnings | 187 | 186 | +0.5% |
| Net Income Loss Attributable To Noncontrolling Interest | 4 | 5 | -20.0% |
| Net Income | 187 | 186 | +0.5% |
| EPS (Basic) | 1.54 | 1.51 | +2.0% |
| EPS (Diluted) | 1.54 | 1.5 | +2.7% |
| Wtd Avg Shares (Basic) | 121,363 | 123,367 | -1.6% |
| Wtd Avg Shares (Diluted) | 121,787 | 124,066 | -1.8% |
| Comprehensive Income | 194 | 191 | +1.6% |
| Foreign Currency Transaction Gain Loss Before Tax | 2 | -1 | +300.0% |
| Gain Loss On Investments | 3 | 2 | +50.0% |
Balance Sheet
| Metric | Q3 2026 | Q3 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 1,187 | — | — |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level1 · Money Market Funds | 715 | — | — |
| Fair Value Inputs Level2 · Bank Time Deposits | 332 | — | — |
| Receivables Net Current | 671 | 597 | +12.4% |
| Inventory | 588 | — | — |
| Prepaid Expenses & Other Current Assets | 205 | 132 | +55.3% |
| Total Current Assets | 2,651 | 1,590 | +66.7% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 1,235 | 1,245 | -0.8% |
| Operating Lease Right-of-Use Assets | 355 | 349 | +1.7% |
| Goodwill | 1,229 | 1,222 | +0.6% |
| Other Non-Current Assets | 415 | 537 | -22.7% |
| Total Assets | 6,436 | — | — |
Show Business Segments breakouts |
|||
| Health and Wellness · Operating Segments | 1,198 | — | — |
| Household · Operating Segments | 1,085 | — | — |
| International · Operating Segments | 1,306 | — | — |
| Lifestyle · Operating Segments | 1,098 | — | — |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 1,749 | — | — |
Show Fair Value By Measurement Basis breakouts |
|||
| Carrying Reported Amount Fair Value Disclosure | 1,218 | — | — |
| Other Assets | |||
| Trademarks Net | 502 | 501 | +0.2% |
| Other Intangible Assets Net | 49 | 68 | -27.9% |
| Current Liabilities | |||
| Commercial Paper | 1,591 | — | — |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level2 · Carrying Reported Amount Fair Value Disclosure | 1,591 | — | — |
| Operating Lease Liability Current | 85 | 85 | 0.0% |
| Accounts Payable And Accrued Liabilities Current | 1,479 | 2,016 | -26.6% |
| Total Current Liabilities | 3,155 | 2,155 | +46.4% |
| Non-Current Liabilities | |||
| Long-Term Debt | 2,487 | 2,483 | +0.2% |
| Operating Lease Liabilities | 323 | 322 | +0.3% |
| Other Non-Current Liabilities | 356 | 341 | +4.4% |
| Deferred Tax Liabilities | 23 | 21 | +9.5% |
| Total Liabilities | 6,344 | — | — |
Show Fair Value By Measurement Basis breakouts |
|||
| Carrying Reported Amount Fair Value Disclosure | 4,078 | — | — |
| Long-Term Debt (Q) | — | — | — |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level2 · Carrying Reported Amount Fair Value Disclosure | 2,487 | — | — |
| Stockholders' Equity | |||
| Common Stock | 131 | 131 | 0.0% |
| Additional Paid In Capital Common Stock | 1,315 | 1,304 | +0.8% |
| Retained Earnings | 223 | 99 | +125.3% |
| Treasury Stock Common Value | -1,584 | — | — |
| Accumulated Other Comprehensive Income | -152 | -176 | +13.6% |
| Total Stockholders' Equity | -67 | — | — |
| Minority Interest | 159 | 163 | -2.5% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 92 | 190 | -51.6% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -2 | -2 | 0.0% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 80 | 78 | +2.6% |
| Accumulated Other Comprehensive Income | -152 | -176 | +13.6% |
| Accumulated Translation Adjustment | -230 | -252 | +8.7% |
| Additional Paid In Capital | 1,315 | 1,304 | +0.8% |
| Common Stock | 131 | 131 | 0.0% |
| Noncontrolling Interest | 159 | 163 | -2.5% |
| Retained Earnings | 223 | 99 | +125.3% |
| Treasury Stock Common | -1,584 | -1,331 | -19.0% |
| Total Liabilities & Equity | 6,436 | 5,512 | +16.8% |
Cash Flow Statement
| Metric | YTD Q3 2026 | YTD Q3 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 169 | 162 | +4.3% |
Show Business Segments breakouts |
|||
| Health and Wellness · Operating Segments | 44 | 42 | +4.8% |
| Household · Operating Segments | 63 | 58 | +8.6% |
| International · Operating Segments | 32 | 31 | +3.2% |
| Lifestyle · Operating Segments | 20 | 18 | +11.1% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 10 | 13 | -23.1% |
| Stock-Based Compensation | 49 | 64 | -23.4% |
Show Business Segments breakouts |
|||
| Health and Wellness · Operating Segments | 12 | 12 | 0.0% |
| Household · Operating Segments | 8 | 9 | -11.1% |
| International · Operating Segments | 4 | 5 | -20.0% |
| Lifestyle · Operating Segments | 6 | 6 | 0.0% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 19 | 32 | -40.6% |
| Deferred Income Taxes | 135 | -16 | +943.8% |
| Payment For Venture Agreement Termination | -476 | — | — |
| Other Non-Cash Items | -18 | -9 | -100.0% |
| Increase Decrease In Receivables | 158 | 71 | +122.5% |
| Change in Inventory | -64 | -54 | -18.5% |
| Change in Prepaid & Other Assets | -14 | -28 | +50.0% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -12 | -87 | +86.2% |
| Operating Lease Right Of Use Asset And Liability Net | -5 | 1 | -600.0% |
| Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | -74 | -17 | -335.3% |
| Net Cash from Operations | 282 | 687 | -59.0% |
| Investing Activities | |||
| Capital Expenditures | -121 | -145 | +16.6% |
| Other Investing Activities | 1 | -1 | +200.0% |
| Net Cash from Investing | -120 | -18 | -566.7% |
| Financing Activities | |||
| Proceeds From Repayments Of Short Term Debt | 1,581 | 50 | +3062.0% |
| Share Repurchases | -256 | -257 | +0.4% |
| Payments Of Dividends Common Stock | -452 | -452 | 0.0% |
| Issuance Of Common Stock For Employee Stock Plans And Other | -16 | 30 | -153.3% |
| Net Cash from Financing | 857 | -645 | +232.9% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -2 | -2 | 0.0% |
| Net Change in Cash | 1,017 | 22 | +4522.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1,187 | 229 | +418.3% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.